

QUICK LINKS
Purvalanol A is a potent and selective inhibitor of cyclin-dependent kinases (CDKs). It functions by competitively binding to the ATP-binding site of CDKs. This inhibition leads to cell cycle arrest at the G2/M phase, ultimately suppressing cell proliferation. Purvalanol A may induce apoptosis in certain cancer cell lines by disrupting the cell cycle progression. Its mode of action involves the regulation of key proteins involved in cell cycle control, such as cyclins and CDK inhibitors. By targeting specific CDKs, Purvalanol A serves as a function for studying the molecular mechanisms underlying cell cycle regulation.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
5-Hydroxy-2-methoxybenzaldehyde, 250 mg | sc-318796 | 250 mg | $278.00 |